News / Events

Abeona Therapeutics to Present Data for ABO-401 in Cystic Fibrosis and Retinal Disorders at the American Society of Gene and Cell Therapy Annual Meeting

Abeona Therapeutics Receives FDA Fast Track Designation for ABO-101 for Treatment of Sanfilippo Syndrome Type B (MPS IIIB)

American Society of Gene and Cell Therapy 22nd Annual Meeting

Apr 29 – May 2, 2019

Annual Meeting of Stockholders

May 28, 2019 • 10:00am EDT